• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus.

作者信息

Vert P, Bianchetti G, Marchal F, Monin P, Morselli P L

出版信息

Eur J Clin Pharmacol. 1980 Jul;18(1):83-8. doi: 10.1007/BF00561483.

DOI:10.1007/BF00561483
PMID:7398752
Abstract
摘要

相似文献

1
Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus.吲哚美辛治疗早产儿动脉导管未闭的有效性及药代动力学
Eur J Clin Pharmacol. 1980 Jul;18(1):83-8. doi: 10.1007/BF00561483.
2
Pharmacokinetics and clinical efficacy of indomethacin in premature infants with patent ductus arteriosus.吲哚美辛在动脉导管未闭早产儿中的药代动力学及临床疗效
Int J Clin Pharmacol Res. 1984;4(2):109-12.
3
Tolerance of intravenous indomethacin treatment for premature infants with patent ductus arteriosus.静脉注射吲哚美辛治疗早产儿动脉导管未闭的耐受性
BMJ. 1988 Sep 24;297(6651):773-4. doi: 10.1136/bmj.297.6651.773.
4
Indomethacin and the preterm infant with a patent ductus arteriosus: relationship between plasma concentration and ductus closure.
Dev Pharmacol Ther. 1982;4(1-2):37-46. doi: 10.1159/000457389.
5
[Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].早产儿动脉导管未闭。吲哚美辛治疗（作者译）
Arch Fr Pediatr. 1981 Aug-Sep;38(7):503-8.
6
Commentary: new thoughts on an old problem--patent ductus arteriosus in the premature infant.
J Pediatr. 1977 Feb;90(2):338-40. doi: 10.1016/s0022-3476(77)80689-6.
7
[Treatment of patent ductus arteriosus in premature infants by indomethacin].
Presse Med. 1987 Jun 6;16(21):1035-8.
8
Drug induced closure of patent ductus arteriosus.药物诱导动脉导管未闭闭合
Heart. 1996 Nov;76(5):384-5. doi: 10.1136/hrt.76.5.384.
9
[Drug therapy of patent ductus arteriosus in premature and newborn infants].
Kinderarztl Prax. 1978 Dec;46(12):644-8.
10
Indomethacin therapy in premature infants with patent ductus arteriosus.
Paediatr Indones. 1982 Mar-Apr;22(3-4):70-6.

引用本文的文献

1
The Relationship of Indomethacin Exposure With Efficacy and Renal Toxicity Outcomes for Preterm Infants in the Neonatal Intensive Care Unit.新生儿重症监护病房中吲哚美辛暴露与早产儿疗效及肾毒性结局的关系
Clin Transl Sci. 2025 May;18(5):e70251. doi: 10.1111/cts.70251.
2
Genetics of the patent ductus arteriosus (PDA) and pharmacogenetics of PDA treatment.动脉导管未闭（PDA）的遗传学和 PDA 治疗的药物遗传学。
Semin Fetal Neonatal Med. 2018 Aug;23(4):232-238. doi: 10.1016/j.siny.2018.02.006. Epub 2018 Feb 24.
3
Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus. A population pharmacokinetic study.

本文引用的文献

1
Pharmacokinetics of indomethacin in the premature infant.
Dev Pharmacol Ther. 1980;1(2-3):111-24.
2
The contribution of PDA in the neonate with severe RDS.
J Pediatr. 1980 Jan;96(1):79-87. doi: 10.1016/s0022-3476(80)80336-2.
3
Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis.通过抑制前列腺素合成来闭合早产儿的动脉导管。
N Engl J Med. 1976 Sep 2;295(10):530-3. doi: 10.1056/NEJM197609022951004.
4
静脉注射吲哚美辛用于有症状的动脉导管未闭早产儿。一项群体药代动力学研究。
Br J Clin Pharmacol. 2004 Sep;58(3):249-58. doi: 10.1111/j.1365-2125.2004.02139.x.
4
Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.婴儿肝脏和肾脏全身清除途径的个体发生：第二部分。
Clin Pharmacokinet. 2002;41(13):1077-94. doi: 10.2165/00003088-200241130-00005.
5
Effects of repeated indomethacin administration on cerebral oxygenation and haemodynamics in preterm infants: combined near infrared spectrophotometry and Doppler ultrasound study.反复给予吲哚美辛对早产儿脑氧合及血流动力学的影响：近红外分光光度法与多普勒超声联合研究
Eur J Pediatr. 1994 Jul;153(7):504-9. doi: 10.1007/BF01957006.
6
Clinical Pharmacokinetics of indomethacin.吲哚美辛的临床药代动力学
Clin Pharmacokinet. 1981 Jul-Aug;6(4):245-58. doi: 10.2165/00003088-198106040-00001.
7
Variability of serum indomethacin concentrations after oral and intravenous administration to preterm infants.
Eur J Pediatr. 1982 Mar;138(2):151-3. doi: 10.1007/BF00441143.
8
Patent ductus arteriosus in premature babies.早产儿动脉导管未闭
Br Med J (Clin Res Ed). 1981 Dec 5;283(6305):1490-2. doi: 10.1136/bmj.283.6305.1490.
9
Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.非甾体抗炎药的临床药代动力学
Clin Pharmacokinet. 1983 Jul-Aug;8(4):297-331. doi: 10.2165/00003088-198308040-00003.
10
Interagency regulatory liaison group workshop on reproductive toxicity risk assessment.跨部门监管联络小组生殖毒性风险评估研讨会
Environ Health Perspect. 1986 Apr;66:193-221. doi: 10.1289/ehp.8666193.
Failure of indomethacin therapy to induce closure of patent ductus arteriosus in premature infants with respiratory distress syndrome.
吲哚美辛治疗未能使患有呼吸窘迫综合征的早产儿动脉导管未闭闭合。
J Pediatr. 1977 Oct;91(4):621-3. doi: 10.1016/s0022-3476(77)80519-2.
5
Pharmacologic closure of patent ductus arteriosus in the premature infant.早产儿动脉导管未闭的药物性闭合
N Engl J Med. 1976 Sep 2;295(10):526-9. doi: 10.1056/NEJM197609022951003.
6
Age-dependent closure of the patent ductus arteriosus by indomethacin.
Pediatrics. 1978 Nov;62(5):706-12.
7
Displacement of bilirubin from albumin by indomethacin.吲哚美辛使胆红素从白蛋白上解离。
J Clin Pharmacol. 1978 Oct;18(10):477-81. doi: 10.1002/j.1552-4604.1978.tb01575.x.
8
Quantitative gas-liquid chromatographic method for the determination of indomethacin in biological fluids.
J Chromatogr. 1978 Jun 1;153(1):189-94. doi: 10.1016/s0021-9673(00)89871-4.
9
Significance of the prostaglandin system to the control of muscle tone of the ductus arteriosus.前列腺素系统对动脉导管肌张力控制的意义。
Adv Prostaglandin Thromboxane Res. 1978;4:325-33.
10
Gestational age and indomethacin elimination in the neonate.
Clin Pharmacol Ther. 1979 Dec;26(6):746-51. doi: 10.1002/cpt1979266746.